Celltrion anticancer biosimilar Vegzelma approved by Medicines and Healthcare products Regulatory Agency
Vegzelma, a Celltrion biosimilar of the anticancer drug Avastin, was approved for sale by Britain's Medicines and Healthcare products Regulatory Agency (MHRA), the company said Monday.